W. Johnson

发表

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

G. Salles, A. Zelenetz, S. Horwitz, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemoradiotherapy for esophageal cancer using weekly Paclitaxel and Carboplatin plus infusional 5-Fluorouracil.

D. Gannett, Jeannie Louie, R. Wolf, 2007, Gastrointestinal cancer research : GCR.

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA

K. Savage, H. Schoder, A. Dogan, 2023, Hematological Oncology.